Search
for
Sort by
Research 151–180 of 1000+
- Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review
- Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease
- Profile of the progesterone derivative chlormadinone acetate — Pharmocodynamic properties and therapeutic applications
- Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Management of acne vulgaris with hormonal therapies in adult female patients
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- Acne
- Implanon<sup>®</sup> and alopecia
- Frontal fibrosing alopecia: Iatrogenic endocrine disruption
- Ductal breast cancer in a male patient
- АСПЕКТИ ПАТОГЕНЕЗУ ТА ДИФЕРЕНЦІЙОВАНІ ПІДХОДИ ДО ЛІКУВАННЯ ПАТОЛОГІЇ ШКІРИ У ЖІНОК РАННЬОГО РЕПРОДУКТИВНОГО ВІКУ З ПОРУШЕННЯМИ МЕНСТРУАЛЬНОГО ЦИКЛУ
- Framing the Problem: The Mystery of Post-Finasteride Syndrome and Reasons to Suspect a Microbial Factor
- Framing the Problem: The Mystery of Post-Finasteride Syndrome and Reasons to Suspect a Microbial Factor
- An adolescent girl presenting with primary amenorrhea: A case report of complete androgen insensitivity syndrome
- Cell-free fat extract restores hair loss: a novel therapeutic strategy for androgenetic alopecia
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- Clinical Snippets
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Estrogens and Human Scalp Hair Growth—Still More Questions than Answers
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Aromatase inhibitors induce ‘male pattern hair loss’ in women?
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Impact of CDK4/6 inhibitors on health-related quality of life outcomes in patients with metastatic breast cancer: A systematic review and meta-analysis
- A case of aromatase inhibitor‐induced alopecia successfully treated with low‐dose oral minoxidil
- Biology of the Hair Follicle: The Basics
- Pharmacology of different progestogens: the special case of drospirenone
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- The Molecular Basis of Androgen Insensitivity